Popular Articles

Arizona Senate Approves Two Bills Related To Abortion Rights
The Arizona Senate on Tuesday approved two abortion-related bills, including one that would increase requirements for obtaining abortions in the state and one that would increase penalties for performing a certain abortion procedure later in pregnancy, the Arizona Republic reports. The first bill (H.B. 2564), which passed 16-12, would impose a 24-hour waiting period before abortion procedures, require that abortion providers inform patients about risks and alternatives, and increase parental consent requirements for minors. Although the state has had a written parental consent requirement since 2003, the new measure would require that the consent form be notarized (Newton, Arizona Republic, 6/24). According to the AP/Houston Chronicle, the bill also would "allow pharmacists and other health care providers to refuse to hand out emergency contraception on moral or religious grounds" (Davenport, AP/Houston Chronicle, 6/23). The second bill (H.B. 2400) would impose a fine or two-year prison sentence for violating the state"s law banning intact dilation and extraction procedures, which currently is punishable by one year in prison (Arizona Republic, 6/24).Paul Senseman, a spokesperson for Gov. Jan Brewer (R), said that the governor has not decided whether she will sign the bills. Senseman previously has said that Brewer "has a very consistent pro-life record. Republican leaders in the state Legislature have attempted for years to increase abortion restrictions, but former Gov. Janet Napolitano (D) vetoed every measure on the subject" (Arizona Republic, 6/24).Opponents of H.B. 2564 said that it would make it difficult for women to access abortion services, especially for women outside of urban areas who would have to make multiple trips to providers under the waiting period requirement. According to Planned Parenthood, the bill would reduce the number of communities in the state where abortion is available from 10 to three. Supporters of the bill contend that it would better inform women about risks and alternatives to abortion (AP/Houston Chronicle, 6/23).
generic viagra online
Sen. Grassley Pushes For Exclusion Of Abortion Coverage In Health Care Reform Legislation
Senate Finance Committee ranking member Chuck Grassley (R-Iowa) and committee Chair Max Baucus (D-Mont.) have been privately negotiating over how their panel"s version of health reform legislation will address abortion coverage, Newsweek reports. According to Newsweek, Grassley has been pushing to include measures that would prohibit what he considers "taxpayer-subsidized abortion."Earlier this month, NARAL Pro-Choice America, Raising Women"s Voices and other women"s health advocates intensified efforts to ensure that abortion access was treated like access to all other services in health care reform, according to Newsweek. The article points out, "Though usually publicly debated in the language of personal liberty and morality, abortion is a medical procedure performed by a doctor. It"s currently covered by most private insurance plans and existing government programs, at least under some circumstances. This expanded federal oversight and use of federal dollars raises several thorny issues." Grassley is urging that federally regulated and subsidized plans be prohibited from covering the procedure. Lawmakers also could weigh whether religious organizations -- such as Catholic hospitals or health plans -- could opt out of the coverage.Jill Kozeny, Grassley"s spokesperson, said the senator "is opposed to mandating abortion coverage in health care legislation." According to his office, "At one point during the recent negotiations, there was a (compromise) solution that didn"t work out." Grassley -- who is known as a staunch opponent of abortion rights -- said in March, "I take a view that there is almost anything compromisable in public affairs. Abortion is about the only issue I know of that"s not compromisable."Baucus" office declined to comment on the legislation, citing "longstanding Finance Committee policy not to discuss the specifics of ongoing negotiations." Erin Shields, Baucus" press secretary, noted that the lawmaker has a 100% approval rating from NARAL. She added, "He has always fought for a woman"s right to choose and will continue to do so."According to Newsweek, the House"s and the Senate Health, Education, Labor and Pensions Committee"s proposals do not specify covered benefits, instead leaving the decision to an independent commission or the HHS secretary. A recent National Women"s Law Center poll found that 62% of participants would oppose a provision excluding abortion and family planning coverage (Feder, Newsweek, 7/14).
Nutrition

Baxter Advances To Full-Scale Production Of A/H1N1 Vaccine

Baxter International Inc. (NYSE: BAX) announced that it has completed testing and evaluation of the A/H1N1 influenza virus and is now in full-scale production of a commercial A/H1N1 vaccine using its Vero cell culture technology. Baxter received an A/H1N1 strain from the U.S. Centers for Disease Control and Prevention [a World Health Organization (WHO) Collaborating Center] in early May and is diligently working to deliver a pandemic vaccine for use as early as July. WHO raised the pandemic alert level to phase 6, indicating a global influenza pandemic involving the 2009 A/H1N1 strain. Baxter is in contact with WHO and other global public health authorities regarding the pandemic. A number of national public health authorities have existing pandemic agreements with Baxter that allow them to place orders for a vaccine now that a pandemic has been declared by WHO. These public health authorities will be evaluating their needs to determine their orders for vaccine supply. Despite the company"s existing obligations to supply vaccine under a pandemic phase 6 alert, Baxter is also committed to working with WHO to allocate a portion of the company"s commercial production to address global public health issues deemed most urgent. Using its Vero cell technology, Baxter has received European Medicines Agency (EMEA) approval for a mock-up pandemic vaccine called CELVAPAN, the brand name for the company"s pandemic vaccine. The qualification, development and manufacturing processes used in gaining mock-up licensure for CELVAPAN apply as the company uses this new influenza A/H1N1 virus strain to produce a pandemic vaccine. The CELVAPAN EMEA licensure supports fast track approval of a pandemic vaccine containing the A/H1N1 virus strain. Baxter will submit the A/H1N1 vaccine for approval upon completion of initial manufacturing runs. Baxter"s research and development, manufacturing capabilities and pandemic planning expertise allow the company to efficiently develop candidate vaccines against potentially emerging influenza viruses. Baxter believes that its Vero cell technology can be used to safely and reliably produce a vaccine in response to this global public health issue. It is possible that Baxter"s Vero cell technology may offer advantages, in that it may allow more rapid production and delivery of pandemic vaccines. Baxter International Inc.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):